Exact Mass: 397.0096
Exact Mass Matches: 397.0096
Found 60 metabolites which its exact mass value is equals to given mass value 397.0096,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Tyrphostin AG 825
cefetamet
Sinigrin
Sinigrin is a major glucosinolate present in plants of the Brassicaceae family. Sinigrin inhibits early-stage adipogenesis of 3T3-L1 adipocytes through the AMPK and MAPK signaling pathways. Sinigrin has potent anti-oxidant, anti-tumor and anti-inflammatory effects[1]. Sinigrin is a major glucosinolate present in plants of the Brassicaceae family, with anti-adipogenic effects[1]. Sinigrin is a major glucosinolate present in plants of the Brassicaceae family, with anti-adipogenic effects[1].
AG-825
D000970 - Antineoplastic Agents > D020032 - Tyrphostins
Sinigrin
2-propenyl glucosinolate, also known as sinigrin, monopotassium salt or myronate, is a member of the class of compounds known as alkylglucosinolates. Alkylglucosinolates are organic compounds containing a glucosinolate moiety that carries an alkyl chain. 2-propenyl glucosinolate is soluble (in water) and an extremely strong acidic compound (based on its pKa). 2-propenyl glucosinolate can be found in brussel sprouts, which makes 2-propenyl glucosinolate a potential biomarker for the consumption of this food product. Sinigrin is a major glucosinolate present in plants of the Brassicaceae family. Sinigrin inhibits early-stage adipogenesis of 3T3-L1 adipocytes through the AMPK and MAPK signaling pathways. Sinigrin has potent anti-oxidant, anti-tumor and anti-inflammatory effects[1]. Sinigrin is a major glucosinolate present in plants of the Brassicaceae family, with anti-adipogenic effects[1]. Sinigrin is a major glucosinolate present in plants of the Brassicaceae family, with anti-adipogenic effects[1].
3,5-Pyridinedicarboxylic acid, 4-(2,3-dichlorophenyl)-2,6-dimethyl-, 2-hydroxyethyl methyl ester
Methyl 6-((4-bromo-2-chlorophenyl)amino)-7-fluoro-1H-benzo[d]imidazole-5-carboxylate
5-((4-BROMO-2-CHLOROPHENYL)AMINO)-4-FLUORO-1-METHYL-1H-BENZO[D]IMIDAZOLE-6-CARBOXYLIC ACID
Thiazolidine, 3-[(4-bromophenyl)sulfonyl]-2-(4-methylphenyl)- (9CI)
Ethyl 2-(3-bromo-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylate
4-(3-Chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-yl acetate hydrochloride
Cefetamet
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DD - Third-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
2H-1,2,4-Benzothiadiazine-7-sulfonamide,6-chloro-3,4-dihydro-2-methyl-3-[(2-propen-1-ylthio)methyl]-, 1,1-dioxide
3-[2-chloro-4-[(2,6-dichloro-4-nitrophenyl)azo]anilino]propiononitrile
N-[2-(Benzyloxy)-5-(bromoacetyl)phenyl]methanesulfonamide
(5S)-4-ethyl-5-methyl-5-(7-oxa-4-azabicyclo[4.1.0]hepta-1(6),2,4- trien-5-ylsulfanyl)-3,4-dihydrooxazol-1-ium-2-amine hexafluoropho sphate
SKF 83959 hydrobromide
SKF83959 hydrobromide is a potent and selective dopamine D1-like receptor partial agonist. SKF83959 hydrobromide Ki values for rat D1, D5, D2 and D3 receptors are 1.18, 7.56, 920 and 399 nM, respectively. SKF83959 hydrobromide is a potent allosteric modulator of sigma (σ)-1 receptor. SKF83959 hydrobromide belongs to benzazepine family and has improvements on cognitive dysfunction. SKF83959 hydrobromide can be used for the research of Alzheimer's disease and depression[1][2][3][4].
7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DD - Third-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
N-(2-Chlorobenzoyl)-5-(trifluoromethoxy)-1H-indole-2-carbohydrazide
2-(4-Methylsulfonyl-2-nitrophenyl)sulfinylacetic acid (phenylmethyl) ester
4-chloro-N-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl]benzamide
1-[4-(Benzenesulfonyl)-1-piperazinyl]-2-[(4-methyl-2-thiazolyl)thio]ethanone
1-[[(4-Bromo-2-methyl-3-pyrazolyl)-oxomethyl]amino]-3-(2-methoxy-5-methylphenyl)thiourea
N-[1,4-dioxo-3-(1-pyridin-1-iumyl)-2-naphthalenyl]-2-thiophenesulfonamide
2-(3,4-dimethoxyphenyl)-N-[(4-iodophenyl)methyl]ethanamine
(+)-geodin(1-)
A phenolate anion that is the conjugate base of (+)-geodin, arising from the deprotonation of the hydroxy group. Major species at pH 7.3.
p-nitro-Pifithrin-α
p-nitro-Pifithrin-α, a cell-permeable analog of pifithrin-α, is a potent p53 inhibitor. p-nitro-Pifithrin-α suppresses p53-mediated TGF-β1 expression in HK-2 cells. p-nitro-Pifithrin-α inhibits the activation of caspase-3 by Zika virus (ZIKV) strains. p-nitro-Pifithrin-α attenuates steatosis and liver injury in mice fed a high-fat diet [4]. non-alcoholic fatty liver disease[1][2][3].
allylglucosinolate
{"Ingredient_id": "HBIN015249","Ingredient_name": "allylglucosinolate","Alias": "NA","Ingredient_formula": "C10H16KNO9S2","Ingredient_Smile": "C=CCC(=NOS(=O)(=O)[O-])SC1C(C(C(C(O1)CO)O)O)O.[K+]","Ingredient_weight": "397.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "21380","PubChem_id": "44135691","DrugBank_id": "NA"}
